drugset / Trial / NCT00068081

Controlled Study of NGX-4010 for the Treatment of Postherpetic Neuralgia

NCT00068081

Phase 3 Completed 150 enrolled NeurogesX
RandomizedDouble-blindTreatment

Summary

The purpose of the study is to assess the efficacy, safety and tolerability of NGX 4010 applied for 60 minutes for the treatment of PHN.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Capsaicin Small molecule 8 % Topical

Indications